Stopping PCP prophylaxis

被引：0
|
作者：
不详
机构：
来源：
AIDS PATIENT CARE AND STDS | 1999年 / 13卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [21] PCP Prophylaxis in Patients With IBD on Chronic Steroids: A Need for Clearer Guidelines
    Kathuria, Siddarth
    Sequeira, Herman
    Scatena, Robyn
    CHEST, 2016, 150 (04) : 164A - 164A
  • [22] DOES DRUG-INTERACTION CAUSE FAILURE OF PCP PROPHYLAXIS WITH DAPSONE
    HUENGSBERG, M
    CASTELINO, S
    SHERRARD, J
    OFARRELL, N
    BINGHAM, J
    LANCET, 1993, 341 (8836): : 48 - 48
  • [23] Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
    Stern, Anat
    Green, Hefziba
    Paul, Mical
    Vidal, Liat
    Leibovici, Leonard
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [24] Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients
    Green, H.
    Paul, M.
    Vidal, L.
    Leibovici, L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (03):
  • [25] Suboptimal PCP and other prophylaxis increases hospitalization of marginalized populations.
    Russell, J
    Wang, X
    Leon, H
    Palepu, A
    Phillips, P
    Schechter, M
    O'Shaughnessy, M
    Anis, A
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A226 - A226
  • [26] MAC and PCP prophylaxis not needed in HIV patients with sustained immunoresponse to HAART
    不详
    FORMULARY, 1999, 34 (11) : 967 - 967
  • [27] Severe hemophilia: Stopping and tapering prophylaxis in the second and third decade
    Nijdam, A.
    Fischer, K.
    HAEMOPHILIA, 2012, 18 : 163 - 163
  • [28] Assessing the Need for Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis in SLE Patients on Immunosuppression
    Lynch, Kimberly A.
    Guerrero, Maria Salgado
    Jimenez, Alejandra Londono
    Gendlina, Inessa
    Mowrey, Wenzhu B.
    Mokrzycki, Michele H.
    Broder, Anna R.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [29] Q: Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?
    Tabanor, Joy-Ann
    Lakshminarayanan, Santhanam
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2019, 86 (07) : 449 - 453
  • [30] MAXIMIZING THE USE OF TMP-SMZ FOR PCP PROPHYLAXIS IN PEDIATRIC ONCOLOGY PATIENTS
    Narla, Anu
    Bernt, Kathrin
    Gordon, Peter
    Hettmer, Simone
    Hoffman, Inga
    Lee, Michelle
    Billett, Amy
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 829 - 829
12345